Policy / Pricing AbbVie tries a new approach in 340B programme battle PharmaphorumAbbVie has opened a new front in the pharma industry's efforts to reform the 340B drug discounting programme for safety net hospitals in the US.Policy / PricingRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaphorum AbbVie has opened a new front in the pharma industry’s efforts to reform the 340B drug discounting programme for safety net hospitals in the US. Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: The FTC Blows Up Express Scripts’ PBM Model–and Launches the Net Pricing Drug Channel (rerun)Next: Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
